Type 2 Papillary Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Type 2 Papillary Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating tivantinib with or without erlotinib in metastatic or locally advanced renal cell carcinoma that cannot be surgical…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with or without TRC105 in metastatic kidney cancer has completed with results posted.